Loic Jule
Managing Director - Global Investment Partnerships Portfolio @ PSP Investments
Montréal, Canada
Loic Jule is a Series D investor at PSP Investments in Montréal focused on Medical and Health Care. Loic Jule is the managing director of global investment partnerships portfolio at PSP Investments.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Loic Jule invests in
Stages Loic Jule invests in
Countries Loic Jule invests in
Investment Focus
Industry
- Medical 1 (33%)
- Health Care 1 (33%)
- Therapeutics 1 (33%)
- Biotechnology 1 (33%)
- Medical Device 1 (33%)
Stage
- Series D 1 (33%)
- Series E 1 (33%)
- Funding Round 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
RefleXion Medical
|
RefleXion is developing the first biology-guided radiotherapy system, a significant change in strategy from single tumor therapy to the ability to one day treat multiple tumors in the same treatment session in cancers that have metastasized. Currently, the RefleXion X1 machine is cleared for the delivery of stereotactic body radiotherapy (SBRT),stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) imaging data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with subsecond latency. | $80M / Mar 10, 2022 | |
|
RefleXion Medical
|
RefleXion is developing the first biology-guided radiotherapy system, a significant change in strategy from single tumor therapy to the ability to one day treat multiple tumors in the same treatment session in cancers that have metastasized. Currently, the RefleXion X1 machine is cleared for the delivery of stereotactic body radiotherapy (SBRT),stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) imaging data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with subsecond latency. | $80M / Series E / Mar 10, 2022 | |
|
RefleXion Medical
|
RefleXion is developing the first biology-guided radiotherapy system, a significant change in strategy from single tumor therapy to the ability to one day treat multiple tumors in the same treatment session in cancers that have metastasized. Currently, the RefleXion X1 machine is cleared for the delivery of stereotactic body radiotherapy (SBRT),stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT). The company is also developing BgRT, which incorporates positron-emission tomography (PET) imaging data to enable tumors to continuously signal their location. The BgRT technology will synchronize these data with the linear accelerator to direct radiotherapy to tumors with subsecond latency. | $100M / Series D / Apr 17, 2020 |
Co-Investors
About PSP Investments
PSP Investments is one of Canada’s largest pension investment managers, with $116.8 billion of assets under management as at March 31, 2016. We invest funds for the pension plans of the Public Service, the Canadian Armed Forces, the Royal Canadian Mounted Police and the Reserve Force.Our skilled and dedicated team of more than 600 professionalsmanages a diversified global portfolio including stocks, bonds and other fixed-income securities, and investments in Private Equity, Real Estate, Infrastructure, Natural Resources and Private Debt.Our business offices are in Montreal, New York, London and Luxembourg. Our head office is in Ottawa.
PSP Investments Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Annie Sorich
TitleSenior Director, Strategy and Business Planning
|
|||
David Court
Director
|
|||
Eduard van Gelderen
SVP and Chief Investment Officer
|
|||
|
Loic Jule
Managing Director - Global Investment Partnerships Portfolio
|
|||
|
Nicholas Lenicheck
Senior Director, Capital Markets Alternatives
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Loic Jule invest in?
Loic Jule invests primarily in Medical, Health Care and Therapeutics startups, most often at Series D and Series E stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Loic Jule last invest?
The most recent investment recorded for Loic Jule closed in Mar 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
